Rodriguez Susan's Insider Trades & SAST Disclosures
Rodriguez Susan's most recent trade in Heron Therapeutics Inc was a trade of 35,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Rodriguez Susan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 17,950 | 87,180 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 17,950 | 87,180 (0%) | 0% | 0 | Common Stock | |
| Veradigm Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 42,106 | 42,106 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 21 May 2024 | 6,703 | 449,092 (0%) | 0% | 7.8 | 52,357 | Common Stock | |
| Ardelyx Inc | Rodriguez Susan | Chief Commercial Officer | 20 Feb 2024 | 6,928 | 452,795 (0%) | 0% | 8.7 | 60,594 | Common Stock | |
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 83,685 | 83,685 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Rodriguez Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 13,948 | 69,230 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | Rodriguez Susan | Chief Commercial Officer | 16 Jan 2024 | 145,000 | 145,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 16 Jan 2024 | 112,750 | 459,723 (0%) | 0% | 0 | Common Stock | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 21 Aug 2023 | 4,733 | 348,687 (0%) | 0% | 3.6 | 16,811 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 23 May 2023 | 4,711 | 353,420 (0%) | 0% | 3.7 | 17,210 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 21 Feb 2023 | 5,586 | 355,131 (0%) | 0% | 3.0 | 16,764 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 05 Jan 2023 | 351,000 | 351,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 05 Jan 2023 | 78,000 | 360,717 (0%) | 0% | 0 | Common Stock | ||
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 77,160 | 77,160 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 38,580 | 55,282 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Nov 2022 | 3,303 | 282,717 (0%) | 0% | 1.9 | 6,439 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Nov 2022 | 131 | 286,042 (0%) | 0% | 1.9 | 254 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Nov 2022 | 22 | 286,020 (0%) | 0% | 2.0 | 43 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Aug 2022 | 3,356 | 286,237 (0%) | 0% | 1.0 | 3,301 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Aug 2022 | 64 | 286,173 (0%) | 0% | 1.0 | 63 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 06 Jun 2022 | 43,010 | 290,503 (0%) | 0% | 0.7 | 27,995 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 06 Jun 2022 | 910 | 289,593 (0%) | 0% | 0.6 | 578 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 20 May 2022 | 3,425 | 333,513 (0%) | 0% | 0.7 | 2,300 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Feb 2022 | 3,400 | 333,938 (0%) | 0% | 0.7 | 2,278 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 06 Jan 2022 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 06 Jan 2022 | 141,000 | 338,031 (0%) | 0% | 0 | Common Stock | ||
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 20,903 | 20,903 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Susan Rodriguez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 10,452 | 16,702 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Nov 2021 | 643 | 197,030 (0%) | 0% | 1.0 | 638 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 20 Aug 2021 | 630 | 44,673 (0%) | 0% | 1.3 | 832 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 20 May 2021 | 611 | 45,303 (0%) | 0% | 7.1 | 4,331 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 22 Feb 2021 | 611 | 45,914 (0%) | 0% | 6.9 | 4,205 | Common Stock | |
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 05 Jan 2021 | 146,755 | 146,755 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 05 Jan 2021 | 32,612 | 46,525 (0%) | 0% | 0 | Common Stock | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 16 Sep 2020 | 6,087 | 13,913 (0%) | 0% | 6.1 | 37,164 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges